Indian foreign investment debate hots up
This article was originally published in Scrip
Executive Summary
The Indian pharma foreign direct investment (FDI) debate – something of a dormant volcano – erupted again toward the fag end of 2014, after a Parliamentary panel took a tough view on such inflows in the case of brownfield deals, only to be followed by reports of the finance ministry seemingly singing a different tune.